Astec Lifesciences - Results play

The stock has been backward integrating as a strategy. Pre Covid the company had its best result in along time. There could be a revival again this quarter. Results are on 29th Oct.

Technically the stock could be breaking out after consolidating for an entire quarter. Long at CMP with stoploss below 1050.

Fundamentally expecting a 100% YOY growth in profits this quarter.